Press

BIBITEC produces clinical supplies for biomimetic immune hormone
BIBITEC, Bielefeld, Germany, September 11 2009 - BIBITEC GmbH, specialized in the production of recombinant proteins, monoclonal antibodies and APIs for use in clinical trials up to phase III, has been assigned to develop a new cell cultivation process
>> more

NewLab BioQuality AG subsidiary completes first process development project for a biosimilar
BIBITEC GmbH (Bielefeld), a 100 % subsidiary of NEWLAB BIOQUALITY AG (Erkrath), has completed a five year project involving the process development and production of erythropoietin. The EPO was produced under GMP-compliance and was...
>> more